首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Novel univariate and multivariate regression methods for the simultaneous analysis of ternary mixture of 1, 4-benzodiazepines in dosage forms and human urine
【24h】

Novel univariate and multivariate regression methods for the simultaneous analysis of ternary mixture of 1, 4-benzodiazepines in dosage forms and human urine

机译:用于同时分析1,4-苯二氮卓类药物和人类尿液的三元混合物同时分析的新型单变量和多元回归方法

获取原文
获取原文并翻译 | 示例
           

摘要

In this paper, novel univariate and multivariate regression model updating methods were developed and validated for the simultaneous determination of ternary mixture of bromazepam, diazepam and clonazepam. The univariate methods used are the mean centering of ratio spectrophotometric method and iso-absorptive point coupled with ratio-subtraction and ratio difference spectrophotometric method. Linearity, ranges, precision and accuracy of these methods were determined. The multivariate methods adopted are the principal component regression and partial least-squares. These models were estimated using nineteen mixtures as calibration set and six mixtures as validation set. The minimum root square error of predication were 0.1215 and 0.0568 for BMZ, 0.0598 and 0.0712 for DIZ and 0.0867 and 0.0753 for CNP by PLS and PCR respectively. PCR and PLS methods were successfully applied for the analysis of BMZ, DIZ and CNP in their dosage forms. Content uniformity testing of the studied pharmaceutical tablets by PLS and PCR was also determined. MCR, IPRSRD and PLS model updating enabled the determination of BMZ, DIZ and CNP in spiked human urine. Moreover, PLS model updating was applied to drug-dissolution rate testing of BMZ and DIZ in their commercial tablets. The obtained results were statistically compared with those obtained by reported methods giving a conclusion that there is no significant difference regarding accuracy and precision.
机译:在本文中,开发并验证了新型单变量和多元回归模型更新方法,同时测定Bromazepam,Diazepam和Clonazepam的三元混合物。使用的单变量方法是比率分光光度法的平均定心和与比率 - 减法和比率分光光度法耦合的均吸收点。确定了这些方法的线性,范围,精度和准确性。采用的多变量方法是主要成分回归和偏最小二乘。这些模型估计使用19个混合物作为校准集和六个混合物作为验证集。 PMZ,0.0598和0.0712的PMZ,0.0867和0.0753分别用于PC,PCR分别为0.1215和0.0568和0.0867和0.0753,分别为0.0867和0.0753。 PCR和PLS方法以它们的剂型成功地应用于分析BMZ,DIZ和CNP。还测定了通过PLS和PCR对所研究的药物片剂的含量均匀性测试。 MCR,IPRSRD和PLS模型更新使得能够在尖刺人尿液中确定BMZ,DIZ和CNP。此外,PLS模型更新应用于商业片中BMZ和DIZ的药物 - 溶解速率测试。将得到的结果与通过报告的方法获得的结果进行了统计学,得出结论,即关于准确性和精度没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号